Niccolò Alberto Elia Venanzi

Niccolò Alberto Elia Venanzi

Auto-generated profile, based on publicly available information

Niccolò Alberto Elia Venanzi

NVIDIA, Santa Clara, CA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2025 in bioRxiv
Verified
Preprint
Open access
MIMichele Invernizzi
Michele Invernizzi
SBSandro Bottaro
Sandro Bottaro
JSJulian O. Streit
Julian O. Streit
BTBruno Trentini
Bruno Trentini
NVNiccolò Alberto Elia Venanzi
Niccolò Alberto Elia Venanzi
KTKamil Tamiola
Kamil Tamiola
While deep learning has transformed structure prediction for ordered proteins, intrinsically disordered proteins remain poorly predicted due to systematic underrepresentation in training data, despite constituting approximately 30% of eukaryotic proteomes. We introduce PeptoneBench, the first benchmark to enable systematic assessment of ensemble generators for both ordered and disordered proteins, integrating diverse experimental observables. Our analysis reveals that existing evaluation metrics exhibit systematic bias toward the structured spectrum of the proteome. Assessment of popular predictors (AlphaFold2, ESMFlow, Boltz2) confirms high accuracy on ordered proteins but shows performance degradation with increasing disorder. We further present PepTron, a flow-matching ensemble generator trained on data augmented with synthetic disordered protein ensembles. On our benchmark PepTron matches BioEmu on disordered regions while maintaining competitive accuracy on ordered protein benchmarks. Our data augmentation approach demonstrates that targeted training strategies can approach the performance of computationally expensive simulation-based methods, establishing a generalizable framework applicable to other protein generative models. All datasets, models, and code are openly available.

16 September 2020 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
WLWilliam J.S. Lockley
William J.S. Lockley
NVNiccolò A. E. Venanzi
Niccolò A. E. Venanzi
GCGeorgie J. Crane
Georgie J. Crane

1 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YHYewon Han
Yewon Han
RNRiya Narain
Riya Narain
RARazan Abbara
Razan Abbara
MAMarcelo Querino Lima Afonso
Marcelo Querino Lima Afonso
JAJeannie Austin
Jeannie Austin
JGJoe Grove
Joe Grove
Mechanistic understanding of viral protein-protein interactions enables global health security and pandemic preparedness, yet experimental characterisation remains difficult, costly, and often restricted to specialised laboratories. Here, we describe an in silico campaign using AlphaFold2 and AlphaFold-Multimer to predict monomers and dimer structures within 2,812 viral proteomes from 23 viral families relevant to human health. We report high-confidence predicted structures of 5,279 hetero-, and 2,749 homo-dimers. Structural clustering of interfaces reduces the set fivefold to 1,598 consolidated by form and function, of which 471 (29.5%) lacked detectable similarity to experimentally determined interfaces in the PDB. These clusters yielded two notable findings: new data on vaccinology-relevant glycoproteins, and accurate prediction of the specificity and cleavage-site recognition of viral proteases, which are targets for anti-viral development. Viral monomers and high-confidence dimers are available for interactive browsing in the Pandemic Preparedness Portal of the AlphaFold Database ( https://alphafold.ebi.ac.uk/ ), and the full dataset is available for bulk download.